Clinical trial
Study of ALGRX 3268 for Needlestick Pain in Children
NCT00132405 · AlgoRx Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00132405 |
|---|---|
| Title | Study of ALGRX 3268 for Needlestick Pain in Children |
| Official title | Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects |
| Lead sponsor | AlgoRx Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | ALGRX 3268 |
| Enrollment | 260 |
| Start date | May 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Aug 22, 2005 |
| Last update posted | Oct 10, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: